The market may be wrong about Revenio’s giant store – “Buy and wait”

Revenio’s stock may now be a good place to strike if the company can foreclose on the synergies from its recent acquisition. In the short term, the price development may stagnate, but for a long-term investor, there may be a unique buying opportunity.

The health technology company Revenio announced a giant acquisition in April. At that time, it was heard that Revenio will acquire the French eye healthcare equipment supplier Visionix, i.e. in practice the French LT International, which is the parent company of the Visionix International group. At the same time, Revenio doubles in size.